Nat Biomed Eng 2020[Apr]; 4 (4): 355-356 PMID32269324show ga
The world needs mass at-home serological testing for antibodies elicited by SARS-CoV-2, and rapid and frequent point-of-care testing for the presence of the virus' RNA in selected populations.